Back
ProShares UltraShort Consumer Discretionary Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
9
SCC
ProShares UltraShort Consumer Discretionary
Last Price:
$13.90
Seasonality Move:
-3.14%
Sell
43
CRSP
CRISPR Therapeutics AG
Last Price:
$55.85
Seasonality Move:
14.46%
Sell
9
ProShares UltraShort Consumer Discretionary (SCC)
is a Sell
Is ProShares UltraShort Consumer Discretionary a Buy, Sell or Hold?
-
The current ProShares UltraShort Consumer Discretionary [SCC] share price is $13.94. The Score for SCC is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
-
SCC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $55.86. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SCC Stock Price Chart
What is ProShares UltraShort Consumer Discretionary's stock price today?
-
The ProShares UltraShort Consumer Discretionary share price today is $13.94Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SCC is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $55.86The current trend is relatively stagnant and CRSP is experiencing slight buying pressure.
SCC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.63 | Buy |
| Relative Strength Index (14 RSI): | 39.81 | Sell |
| Chaikin Money Flow: | 16295 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.1 - 15.8) | Sell |
| Bollinger Bands (100): | (14.29 - 16.05) | Sell |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 49.16 | Sell |
| Chaikin Money Flow: | 78181 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.94 - 57.06) | Buy |
| Bollinger Bands (100): | (52.44 - 65.4) | Sell |
SCC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.11 | Sell |
| 20-day SMA: | 14.64 | Sell |
| 50-day SMA: | 14.87 | Sell |
| 200-day SMA: | 17.79 | Sell |
| 8-day EMA: | 7.41 | Buy |
| 20-day EMA: | 3.63 | Buy |
| 50-day EMA: | 1.58 | Buy |
| 200-day EMA: | 0.41 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.25 | Sell |
| 20-day SMA: | 55.05 | Buy |
| 50-day SMA: | 58.96 | Sell |
| 200-day SMA: | 51.1 | Buy |
| 8-day EMA: | 55.79 | Buy |
| 20-day EMA: | 55.79 | Buy |
| 50-day EMA: | 56.36 | Sell |
| 200-day EMA: | 37.56 | Buy |
ProShares UltraShort Consumer Discretionary Earnings Growth & SCC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
ProShares UltraShort Consumer Discretionary Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||